Stlmt ID US Tech Biotechnology NBX 指数
3995.9 USD
{{ price }}
-4.370199%
{{change_pct}}%
Stlmt ID US Tech Biotechnology 价格走势图
过去24小时内的前5名涨幅最大者
| RIGL | Rigel Pharmaceuticals | +33.37% | |
|---|---|---|---|
| VCYT | Veracyte | +27.46% | |
| DAWN | Day One Biopharmaceuticals | +25.21% | |
| SRPT | Sarepta Therapeutics | +15.25% | |
| FHTX | Foghorn Therapeutics | +13.31% |
过去24小时内的前5名跌幅最大者
| PRLD | Prelude Therapeutics Incorporated | -21.02% | |
|---|---|---|---|
| SUPN | Supernus Pharmaceuticals | -17.35% | |
| CMPS | COMPASS Pathways | -17.19% | |
| SYRS | Syros Pharmaceuticals | -16.67% | |
| LRMR | Larimar Therapeutics | -15.26% |
Stlmt ID US Tech Biotechnology NBX 财务与交易概览
| Stlmt ID US Tech Biotechnology指数价格 | 3995.9 USD |
| 昨日收盘价 | 4745.82 USD |
| 开盘价 | 0 USD |
| 买入价 | 0 USD x 0 |
| 卖出价 | 0 USD x 0 |
| 当日价格范围 | 4555.41 - 4917.8 USD |
| 52 周价格范围 | 4555.41 - 4917.8 USD |
| 成交量 | 0 USD |
| 平均成交量 | N/A |
交易信息
Stlmt ID US Tech Biotechnology 指数价格历史
| 52 周最高 | 4917.8 USD |
| 52 周最低 | 4555.41 USD |
| 50 天移动平均线 | N/A |
| 200 天移动平均线 | N/A |
NBX Index Statistics
| 平均成交量（3 个月） | N/A |
| 平均每日成交量（10 天） | N/A |
Stlmt ID US Tech Biotechnology指数问答
什么是当前的NBX指数价格？
Stlmt ID US Tech Biotechnology NBX指数今天的价格是3995.9 USD。
如何购买Stlmt ID US Tech Biotechnology指数？
您可以在Tech Market交易所购买NBX指数。请联系您的财务顾问以选择经纪商。
Stlmt ID US Tech Biotechnology指数的股票代码是什么？
Stlmt ID US Tech Biotechnology指数的股票代码是NBX。
Stlmt ID US Tech Biotechnology指数包含多少个成分？
Stlmt ID US Tech Biotechnology指数包含388个成分。
Stlmt ID US Tech Biotechnology指数属于哪个国家？
Stlmt ID US Tech Biotechnology指数所属国家是United States。
Stlmt ID US Tech Biotechnology指数属于哪个交易所？
Stlmt ID US Tech Biotechnology指数所属交易所是Tech Market。
Stlmt ID US Tech Biotechnology 成分
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 |
|---|
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 |
|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
| AstraZeneca AZN | $81.65 — |
+0.62
|
$252.6B — | $5.34M — | $81.02 — | $82.09 — | $252.6B — | 30.50 | $2.66 — |
| Amgen AMGN | $319.86 — |
+7.81
|
$172.2B — | $5.32M — | $302.13 — | $322.98 — | $172.2B — | 26.13 | $12.24 — |
| Gilead Sciences GILD | $122.58 — |
-0.34
|
$152.24B — | $6.29M — | $121.71 — | $123.73 — | $152.24B — | 18.97 | $6.46 — |
| Sanofi SNY | $49 — |
-0.22
|
$120.85B — | $1.95M — | $48.55 — | $49.32 — | $120.85B — | 16.22 | $3.02 — |
| Vertex Pharmaceuticals Incorporated VRTX | $417 — |
-1.11
|
$106.91B — | $1.4M — | $410.45 — | $427.18 — | $106.91B — | 29.30 | $14.23 — |
| Regeneron Pharmaceuticals REGN | $644.19 — |
+2.58
|
$67.7B — | $687.89K — | $628 — | $646.89 — | $67.7B — | 15.42 | $41.75 — |
| Alnylam Pharmaceuticals ALNY | $434.56 — |
+2.62
|
$57.41B — | $919.68K — | $417 — | $438.53 — | $57.41B — | 1448.53 | $0.3 — |
| argenx SE ARGX | $832.35 — |
+0.1
|
$51.25B — | $210.19K — | $812.79 — | $834.28 — | $51.25B — | 35.60 | $23.38 — |
| Insmed Incorporated INSM | $186.88 — |
+2.25
|
$39.86B — | $1.57M — | $182.09 — | $189.31 — | $39.86B — | 0 | -$6.18 — |
| BioNTech SE BNTX | $103.43 — |
-1.34
|
$24.87B — | $529.87K — | $103.04 — | $105.2 — | $24.87B — | 0 | -$1.65 — |
| Royalty Pharma RPRX | $40.42 — |
+6.82
|
$23.57B — | $8.86M — | $36.03 — | $40.82 — | $23.57B — | 17.65 | $2.29 — |
| Biogen BIIB | $153.43 — |
+2.75
|
$22.51B — | $1.72M — | $148.9 — | $153.66 — | $22.51B — | 13.99 | $10.96 — |
| Incyte INCY | $105.7 — |
+2.7
|
$20.75B — | $2.74M — | $101.5 — | $106.47 — | $20.75B — | 17.91 | $5.9 — |
| United Therapeutics UTHR | $447.45 — |
+2.31
|
$19.27B — | $392.22K — | $432.53 — | $449.82 — | $19.27B — | 16.97 | $26.36 — |
| Illumina ILMN | $122.44 — |
+4.77
|
$18.71B — | $2.9M — | $120 — | $126 — | $18.71B — | 27.45 | $4.46 — |
| Genmab A/S GMAB | $29.19 — |
+1.5
|
$17.97B — | $2.92M — | $28.08 — | $29.26 — | $17.97B — | 15.12 | $1.93 — |
| Medpace MEDP | $598.81 — |
+0.72
|
$16.87B — | $296.93K — | $585 — | $602.54 — | $16.87B — | 41.81 | $14.32 — |
| Neurocrine Biosciences NBIX | $153.75 — |
+7.37
|
$15.33B — | $2.92M — | $147.7 — | $157.67 — | $15.33B — | 36.69 | $4.19 — |
| Roivant Sciences ROIV | $20.23 — |
+1.81
|
$13.81B — | $9.01M — | $19.62 — | $20.3 — | $13.81B — | 0 | -$1.09 — |
| Summit Therapeutics SMMT | $18.07 — |
+3.32
|
$13.45B — | $2.88M — | $17.37 — | $18.17 — | $13.45B — | 0 | -$1.25 — |
- {{ link.label }} {{link}}